RE:RE:RE:RE:RE:RE:RE:so what happened to $10 like all the sillies This mornings news indicates to me that the delay CIBC was concerned about, may not be as bad as they thought or may not happen at all. They wrote: "after RyplazymTM receives its expected accelerated approval in the fourth quarter of 2017." So we still seem to be on track for a Q4 approval. Also contrary to prior speculation by some, we seem to defintely be in the running for the PV. "Prometic has provided further data to the FDA to support its claims that the serious and life-threatening clinical manifestations associated with congenital plasminogen deficiency occurs predominantly in pediatric patients, as required to qualify for a rare pediatric disease designation."
And we are also moving forward with EMA and Health Canada.
I would say that this is a very positive PR. CIBC should have waited before they dropped their target so hugely. Now they will look very stupid and backstabbing (selling short just before their release..